Our Portfolio
H.I.G. Capital has invested in over 400 companies over our 30+ years. We work closely with our portfolio to drive value creation.
Polygon
Polygon is a leading provider of integrated management of medical equipment in hospitals in Italy and Spain, with 5 offices and over 600 employees. Polygon's offer includes services such as the audit of biomedical equipment, corrective and preventive maintenance, safety checks, calibration, quality control, and in-depth consultancy and design collaboration partnerships with hospitals.
Learn More
Concord, an H.I.G. Capital Portfolio Company, Completes Acquisition of Authentic
SAN FRANCISCO – February 14, 2023 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $54 billion of equity capital under management, is pleased to announce that its portfolio company, Concord USA, LLC (“Concord”), has acquired Authentic Digital …
Learn More
H.I.G. Growth Partners Completes Sale of Eruptr
BOSTON – February 9, 2023 – H.I.G. Growth Partners (“H.I.G. Growth”), the dedicated growth capital investment affiliate of H.I.G. Capital, is pleased to announce the sale of its portfolio company, Eruptr (“Eruptr” or the “Company”), a leading provider of technology-enabled digital …
Learn More
H.I.G. Completes Sale of Medusind
MIAMI – January 12, 2023 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $53 billion of equity capital under management, is pleased to announce the sale of its portfolio company Medusind (“Medusind” or the “Company”) to Alpine …
Learn More
Health Network One, an H.I.G. Capital Portfolio Company, Acquires Premier Eye Care
MIAMI – January 4, 2023 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $53 billion of equity capital under management, is pleased to announce that its portfolio company, Health Network One, has acquired Premier Eye Care, Inc. …
Learn More
Celerion
Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinical trial and bioanalytical services to a diverse group of customers.
Learn More
H.I.G. Capital Completes Sale of Taconic Biosciences
BOSTON – November 1, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $52 billion of equity capital under management, is pleased to announce the sale of its portfolio company Taconic Biosciences (“Taconic” or the “Company”) to Avista …
Learn More
H.I.G. Capital Acquires the Distribution Business of Avient Corporation, Creating Formerra, a New Leader in Polymer Distribution
NEW YORK – November 1, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $52 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the acquisition of the distribution …
Learn More
Barton Associates
Based in Peabody, MA, Barton & Associates is a leading healthcare staffing company focused on locum tenens.
Learn More
H.I.G. Capital Acquires Morningside Healthcare and Morningside Pharmaceuticals
LONDON – October 3, 2022 – H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that its portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside …
Learn More